This inventor holds 1 USPTO granted patent. Top assignee: Health Research, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Sean H. Colligan: Innovator in Cancer Treatment
Introduction
Sean H. Colligan is a notable inventor based in Buffalo, NY (US), recognized for his contributions to cancer treatment methodologies. With a focus on innovative therapies, he has developed a unique approach to combat cancer through combination therapies.
Latest Patents
Sean H. Colligan holds 1 patent for his invention titled "Combination therapy for cancer." This patent outlines methods for treating cancer by administering a combination of treatments aimed at reducing myeloid-derived suppressor cell (MDSC) burden alongside immune therapy. The method includes administering brequinar and an immune checkpoint inhibitor to individuals diagnosed with cancer. This innovative approach seeks to redirect early myeloid precursors away from generating MDSCs, thereby effectively reducing the MDSC burden.
Career Highlights
Colligan is affiliated with Health Research, Inc., where he continues to advance his research in cancer therapies. His work is characterized by a commitment to improving patient outcomes through innovative treatment strategies.
Collaborations
One of his notable collaborators is Scott I. Abrams, with whom he has worked closely to develop and refine his cancer treatment methodologies.
Conclusion
Sean H. Colligan's contributions to cancer treatment through his innovative patent demonstrate his dedication to advancing medical science. His work continues to inspire new approaches in the fight against cancer.